Literature DB >> 21389142

Psychological assessment of primary aldosteronism: a controlled study.

Nicoletta Sonino1, Elena Tomba, Maria Luisa Genesia, Chiara Bertello, Paolo Mulatero, Franco Veglio, Giovanni A Fava, Francesco Fallo.   

Abstract

OBJECTIVE: Our objective was to investigate psychological correlates in a population with primary aldosteronism (PA) using methods found to be sensitive and reliable in psychosomatic research.
METHODS: Twenty-three PA patients (12 male, 11 female; mean age 50 ± 9 yr) were compared with 23 patients with essential hypertension (EH) (15 male, eight female; mean age 47 ± 8 yr) and 23 matched normotensive subjects. A modified version of the Structural Clinical Interview for DSM-IV, a shortened version of the structured interview for the Diagnostic Criteria for Psychosomatic Research, and two self-rating questionnaires, the Psychosocial Index and the Symptom Questionnaire, were administered.
RESULTS: Twelve of 23 patients with PA (52.2%) suffered from an anxiety disorder compared with four of 23 with EH (17.4%) and one control (4.3%) (P < 0.001). Generalized anxiety disorder was more frequent in PA than in EH patients and controls (P < 0.05). As assessed by Diagnostic Criteria for Psychosomatic Research, irritable mood was more frequent in PA and EH compared with controls (P < 0.05) but did not differentiate PA from EH. According to Psychosocial Index results, patients with PA had higher levels of stress (P < 0.01) and psychological distress (P < 0.01) and lower level of well-being (P < 0.05) than controls. Compared with EH patients, PA patients had higher scores in stress subscale (P < 0.05). The Symptom Questionnaire showed higher levels of anxiety (P < 0.01), depression (P < 0.01) and somatization (P < 0.01) and lower physical well-being (P < 0.05) in PA than controls.
CONCLUSION: A role of mineralocorticoid regulatory mechanisms in clinical situations concerned with anxiety and stress is suggested.

Entities:  

Mesh:

Year:  2011        PMID: 21389142     DOI: 10.1210/jc.2010-2723

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  25 in total

Review 1.  The multifaceted mineralocorticoid receptor.

Authors:  Elise Gomez-Sanchez; Celso E Gomez-Sanchez
Journal:  Compr Physiol       Date:  2014-07       Impact factor: 9.090

Review 2.  Aldosterone excess and resistant hypertension: investigation and treatment.

Authors:  Michael Stowasser
Journal:  Curr Hypertens Rep       Date:  2014-07       Impact factor: 5.369

3.  Mood Disorders in Uncontrolled Hypertension Despite Multiple Anti-Hypertensive Medications: Searching for a Link.

Authors:  Alberto Mazza; Roberta Ravenni; Michela Armigliato; Ciro Rossetti; Laura Schiavon; Fulvio Fiorini; Gianluca Rigatelli; Emilio Ramazzina; Edoardo Casiglia
Journal:  High Blood Press Cardiovasc Prev       Date:  2016-01-04

Review 4.  Primary aldosteronism: from bench to bedside.

Authors:  Norlela Sukor
Journal:  Endocrine       Date:  2011-11-01       Impact factor: 3.633

5.  A marked proportional rise in IVC aldosterone following cosyntropin administration during AVS is a signal to the presence of adrenal hyperplasia in primary aldosteronism.

Authors:  G A Kline; J L Pasieka; A Harvey; B So; V C Dias
Journal:  J Hum Hypertens       Date:  2013-11-28       Impact factor: 3.012

Review 6.  Psychological well-being revisited: advances in the science and practice of eudaimonia.

Authors:  Carol D Ryff
Journal:  Psychother Psychosom       Date:  2013-11-19       Impact factor: 17.659

Review 7.  Brain mineralocorticoid receptors in cognition and cardiovascular homeostasis.

Authors:  Elise P Gomez-Sanchez
Journal:  Steroids       Date:  2014-12       Impact factor: 2.668

8.  Central afferents to the nucleus of the solitary tract in rats and mice.

Authors:  Silvia Gasparini; Jacob M Howland; Andrew J Thatcher; Joel C Geerling
Journal:  J Comp Neurol       Date:  2020-06-11       Impact factor: 3.215

9.  Aldosterone-sensitive HSD2 neurons in mice.

Authors:  Silvia Gasparini; Jon M Resch; Sowmya V Narayan; Lila Peltekian; Gabrielle N Iverson; Samyukta Karthik; Joel C Geerling
Journal:  Brain Struct Funct       Date:  2018-10-20       Impact factor: 3.270

10.  Cost-Effectiveness of Screening for Primary Aldosteronism and Subtype Diagnosis in the Resistant Hypertensive Patients.

Authors:  Carrie C Lubitz; Konstantinos P Economopoulos; Stephen Sy; Colden Johanson; Heike E Kunzel; Martin Reincke; G Scott Gazelle; Milton C Weinstein; Thomas A Gaziano
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2015-11-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.